Cargando…

Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers

BACKGROUND AND AIMS: Two of the most lethal gastrointestinal (GI) cancers, gastric cancer (GC) and colon cancer (CC), are ranked in the top five cancers that cause deaths worldwide. Most GI cancer deaths can be reduced by earlier detection and more appropriate medical treatment. Unlike the current “...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Guodong, Wang, Li, Tang, Junlong, Li, Haohui, Pang, Shuyu, Li, Yan, Liu, Li, Hu, Junyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073066/ https://www.ncbi.nlm.nih.gov/pubmed/37014438 http://dx.doi.org/10.1007/s11306-023-02002-0

Ejemplares similares

Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis
por: Mu, Haoran, et al.
Publicado: (2022)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

The efficient circulating immunoscore predicts prognosis of patients with advanced gastrointestinal cancer
por: Zhao, Yamei, et al.
Publicado: (2022)

Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma
por: Cao, Yingying, et al.
Publicado: (2022)

Circulating Metabolites as Potential Biomarkers for Neurological Disorders—Metabolites in Neurological Disorders
por: Donatti, Amanda, et al.
Publicado: (2020)

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018)

Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis
por: Wan, Lingling, et al.
Publicado: (2021)

Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis
por: Li, Haoran, et al.
Publicado: (2022)

A Novel Plasma-Based Methylation Panel for Upper Gastrointestinal Cancer Early Detection
por: Peng, Cheng, et al.
Publicado: (2022)

Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma
por: Zhou, Wen-Da, et al.
Publicado: (2022)

Circulating metabolites serve as diagnostic biomarkers for HER2‐positive breast cancer and have predictive value for trastuzumab therapy outcomes
por: Mao, Changfei, et al.
Publicado: (2022)

Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers
por: Rai, Vikrant, et al.
Publicado: (2023)

Analytical device miniaturization for the detection of circulating biomarkers
por: Natalia, Auginia, et al.
Publicado: (2023)

Circulating lipocalin‐2 as a novel biomarker for early neurological deterioration and unfavorable prognosis after acute ischemic stroke
por: Xie, Yi, et al.
Publicado: (2023)

Combined assay of Circulating Tumor DNA and Protein Biomarkers for early noninvasive detection and prognosis of Non-Small Cell Lung Cancer
por: Yin, Jian-xin, et al.
Publicado: (2021)

Plasma Metabolite Biomarkers for the Detection of Pancreatic Cancer
por: Xie, Guoxiang, et al.
Publicado: (2014)

A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma
por: Luo, Ping, et al.
Publicado: (2018)

Circulating acetaminophen metabolites are toxicokinetic biomarkers of acute liver injury
por: Vliegenthart, ADB, et al.
Publicado: (2016)

Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure
por: Yao, Can, et al.
Publicado: (2021)

The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma
por: Zhao, Lina, et al.
Publicado: (2023)

Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
por: Ng, Enders K. O., et al.
Publicado: (2013)

High-circulating gut microbiota-dependent metabolite trimethylamine N-oxide is associated with poor prognosis in pulmonary arterial hypertension
por: Yang, Yicheng, et al.
Publicado: (2022)

Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis
por: Balaceanu, Lavinia Alice
Publicado: (2019)

TIMP1 is an early biomarker for detection and prognosis of lung cancer
por: Dantas, Ezequiel, et al.
Publicado: (2023)

Circulating miRNAs as Biomarkers for Mitochondrial Neuro-Gastrointestinal Encephalomyopathy
por: Mencias, Mark, et al.
Publicado: (2021)

Detection of Secondary Metabolites as Biomarkers for the Early Diagnosis and Prevention of Type 2 Diabetes
por: Al-Aama, Jumana Y, et al.
Publicado: (2019)

Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer
por: Su, Jian, et al.
Publicado: (2018)

Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer
por: Rasmussen, Louise, et al.
Publicado: (2017)

Circulating Bacterial DNA as Plasma Biomarkers for Lung Cancer Early Detection
por: Zhou, Huifen, et al.
Publicado: (2023)

Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low‐Dose Computed Tomography
por: Kan, Chin Fung Kelvin, et al.
Publicado: (2021)

Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC
por: Li, Yilin, et al.
Publicado: (2023)

Circulating microRNAs as Candidate Biomarkers for the Surveillance of Melanoma Patients
por: Behrmann, Iris, et al.
Publicado: (2015)

A Comprehensive Mass Spectrometry-Based Workflow for Clinical Metabolomics Cohort Studies
por: Shi, Zhan, et al.
Publicado: (2022)

Clinical Study of Sentinel Lymph Node Detection to Evaluate Pelvic Lymph Node Metastasis to Determine the Prognosis of Patients with Early Cervical Cancer
por: Li, Peipei, et al.
Publicado: (2022)

Tryptophan Metabolites as Biomarkers for Esophageal Cancer Susceptibility, Metastasis, and Prognosis
por: Chen, Yun, et al.
Publicado: (2022)

A sensitive and robust plasma-based DNA methylation panel for early detection of target gastrointestinal cancers
por: Dai, Yanmiao, et al.
Publicado: (2023)

Gastrointestinal stromal tumors: Fibrinogen levels are associated with prognosis of patients as blood-based biomarker
por: Lu, Jing, et al.
Publicado: (2018)

Circulating Metabolites as Biomarkers of Disease in Patients with Mesial Temporal Lobe Epilepsy
por: Godoi, Alexandre B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2lnsbl66juiprmsqa5tvlvo3mi